Bronchodilators for bronchiolitis - Gadomski, AM - 2014 | Cochrane Library Skip to Content
Cookies Our site uses cookies to improve your experience. You can find out more about our …

Background Previous systematic reviews have not shown clear benefit of glucocorticoids for
acute viral bronchiolitis, but their use remains considerable. Recent large trials add …

Viral bronchiolitis is a leading cause of acute illness and hospitalization of young children.
Research into the variation in treatment and outcomes for bronchiolitis across different …

Respiratory syncytial virus (RSV) is an important respiratory pathogen in infants and children
worldwide. Although RSV typically causes mild upper respiratory infections, it frequently …

Background Bronchiolitis is the most common lower respiratory tract infection in infants. Up
to 3% of all children in their first year of life are hospitalized with bronchiolitis …

Background The diagnosis of bronchiolitis is based on typical history and results of a
physical examination. The indications for and utility of diagnostic and supportive laboratory …

Objective. To evaluate the efficacy of β2-agonists in bronchiolitis. Design. Critical review and
meta-analysis of randomized controlled trials of inhaled β2-agonists. Results. Three …

Objective: To determine if bronchodilators are efficacious in treating bronchiolitis. Data
Sources: A search of bibliographic databases (MEDLINE, Excerpta Medica, and Reference …

Objective. High incidence, rising admission rates, and relatively ineffective therapies make
the management of bronchiolitis controversial. Since 1980, the rate of hospitalization for …

Objective. Hospital care for children with viral lower respiratory illness (VLRI) is highly
variable, and its relationship to severity and impact on outcome is unclear. Using the …